Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 51Endometrial Neoplasms 21Fallopian Tube Neoplasms 17Sarcoma 9Peritoneal Neoplasms 9Neoplasm Metastasis 7Neoplasms 6Liposarcoma 6Leiomyosarcoma 5Hemangiosarcoma 5Fibrosarcoma 5Carcinoma, Ovarian Epithelial 5Uterine Neoplasms 4Stomach Neoplasms 4Sarcoma, Synovial 4Recurrence 4Neurofibrosarcoma 4Malignant mesenchymal tumor 4Histiocytoma, Malignant Fibrous 4Desmoplastic Small Round Cell Tumor 4Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma, Endometrial Stromal 3Rhabdomyosarcoma 3Hemangiopericytoma, Malignant 3Breast Neoplasms 3Appendiceal Neoplasms 3Sarcoma, Alveolar Soft Part 2Pheochromocytoma 2

Interventions

sodium thiosulfate 1Oxaliplatin 1Mitomycin 1Fluorouracil 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Necrosis × Doxorubicin × Gynecologic × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡